Bioharvest Sciences Stock Today
| CNVCF Stock | USD 5.14 0.22 4.47% |
Performance0 of 100
| Odds Of DistressLess than 20
|
Bioharvest Sciences is trading at 5.14 as of the 8th of November 2024. This is a 4.47 percent increase since the beginning of the trading day. The stock's lowest day price was 5.0. Bioharvest Sciences has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Bioharvest Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of November 2022 and ending today, the 8th of November 2024. Click here to learn more.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. The company has 460.72 M outstanding shares. More on Bioharvest Sciences
Moving against Bioharvest OTC Stock
Bioharvest OTC Stock Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Bioharvest Sciences [CNVCF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 75.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioharvest Sciences's market, we take the total number of its shares issued and multiply it by Bioharvest Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioharvest Sciences classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 460.72 M outstanding shares.
Bioharvest Sciences has accumulated about 1.21 M in cash with (6.79 M) of positive cash flow from operations.
Check Bioharvest Sciences Probability Of Bankruptcy
Ownership AllocationBioharvest Sciences holds a total of 460.72 Million outstanding shares. Bioharvest Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bioharvest Ownership Details
Bioharvest Sciences Risk Profiles
| Mean Deviation | 1.74 | |||
| Standard Deviation | 3.03 | |||
| Variance | 9.19 | |||
| Risk Adjusted Performance | (0.03) |
Bioharvest Stock Against Markets
Picking the right benchmark for Bioharvest Sciences otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bioharvest Sciences otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bioharvest Sciences is critical whether you are bullish or bearish towards Bioharvest Sciences at a given time. Please also check how Bioharvest Sciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bioharvest Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Bioharvest Sciences Corporate Management
Elected by the shareholders, the Bioharvest Sciences' board of directors comprises two types of representatives: Bioharvest Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioharvest. The board's role is to monitor Bioharvest Sciences' management team and ensure that shareholders' interests are well served. Bioharvest Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioharvest Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zaki Rakib | CoFounder Chairman | Profile | |
| BCom BComm | Chief Officer | Profile | |
| Brian Cornblatt | Chief Officer | Profile | |
| David Ryan | S Relations | Profile | |
| Yochi Hagay | CTO CoFounder | Profile | |
| Ilan Sobel | Chief Officer | Profile |
Other Information on Investing in Bioharvest OTC Stock
Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.